Investment
Features
FeesSafety
Academy
More
Pluang+

Compare FirstEnergy Corp. (FE) vs TransMedics Group Inc (TMDX) Price & Performance

FirstEnergy Corp.Trade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

FirstEnergy Corp. vs TransMedics Group Inc — how do they compare? FirstEnergy Corp. trades at $46.86 (market cap $27.06B), while TransMedics Group Inc trades at $89.45 (market cap $3.07B). The key difference: FirstEnergy Corp. is far larger — about 8.8× TransMedics Group Inc's market cap, and FirstEnergy Corp. pays a 3.98% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.

FETMDX
Market Cap
$27.06B$3.07B
Sector
UtilitiesTechnology
52-Week High
$51.91$150.42
52-Week Low
$42.83$61.99
Enterprise Value
$55.98B$3.46B
Dividend Yield
3.98%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

FirstEnergy Corp.

FirstEnergy (FE) trades at $47.47, up 0.2% today, with a bearish technical signal from indicators like the 6-day RSI at 11.10 and ADX signaling strong trend strength. The company reported Q2 2026 EPS of $0.50, slightly missing expectations, but revenue growth is supported by data center demand and a $36 billion grid investment plan. Analyst consensus is a Buy with a $52.67 price target, though technicals suggest near-term pressure.

The outlook is mixed: strong fundamentals with rising revenue and stable margins offer long-term value, but technical bearishness and high debt levels pose risks. Investment opportunity lies in grid expansion and data center growth, while risks include execution challenges and interest rate sensitivity. The stock presents a defensive play with growth potential amid volatility.

TransMedics Group Inc

TMDX trades at $83.89, up 4.59% today, with a bullish technical signal from moving averages and strong support at $81. The company reported a Q2 2026 earnings miss ($0.44 actual vs. $0.50 expected) but beat revenue expectations, with 2025 net income at $190.29M. Analyst consensus is a Buy with a $99.57 price target, though recent news highlights a legal investigation into fiduciary duties.

Outlook remains positive due to raised revenue guidance and institutional interest, but risks include earnings volatility, margin pressure, and legal scrutiny. The stock's valuation multiples suggest growth expectations, yet execution on cost control and international expansion will be critical for sustained upside.

Returns comparison

Trailing returns across standard periods

About FirstEnergy Corp.

FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.

Read more on FE

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX